Status: current, Primitive. Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4964121011 | Bebtelovimab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4964122016 | Bebtelovimab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bebtelovimab | Is a | Antiviral | true | Inferred relationship | Some | ||
| Bebtelovimab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Bebtelovimab | Has disposition | Antiviral | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bebtelovimab-containing product | Has active ingredient | True | Bebtelovimab | Inferred relationship | Some | 1 |
| Bebtelovimab only product | Has active ingredient | True | Bebtelovimab | Inferred relationship | Some | 1 |
| Bebtelovimab only product in parenteral dose form | Has active ingredient | True | Bebtelovimab | Inferred relationship | Some | 1 |
| Bebtelovimab-containing product in parenteral dose form | Has active ingredient | True | Bebtelovimab | Inferred relationship | Some | 1 |
| Bebtelovimab 87.5 mg/mL solution for injection | Has precise active ingredient | True | Bebtelovimab | Inferred relationship | Some | 1 |
| Bebtelovimab 87.5 mg/mL solution for injection | Has BoSS | True | Bebtelovimab | Inferred relationship | Some | 1 |
| Administration of bebtelovimab | Direct substance | True | Bebtelovimab | Inferred relationship | Some | 1 |
| Adverse reaction to bebtelovimab | Causative agent | True | Bebtelovimab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR